December 1, 2015
Velneva’s Clostridium difficile vaccine Candidate meets Phase II trial target
Velneva’s Clostridium difficile vaccine Candidate meets Phase II trial target
Pharmaceuticals, Biotechnology and Life Sciences
Velneva’s Clostridium difficile vaccine Candidate meets Phase II trial target